espestesin 40 mg/ml + 5 microgram/ml solution for injection
pierrel s.p.a. - articaine hydrochloride; epinephrine - solution for injection - amides; articaine, combinations
espestesin forte 40 mg/ml + 10 microgram/ml solution for injection
pierrel s.p.a. - articaine hydrochloride; epinephrine - solution for injection - amides; articaine, combinations
citanest 3% dental octapressin cartridge solution for injection
pierrel pharma s.p.a, italy - prilocaine,felypressin - solution for injection - 30,0.54 µ/ml, mg/m
xylocaine dental adrenaline solu for inj solution for injection
pierrel pharma s.p.a, italy - lidocaine hydrochloride,epinephrine - solution for injection - 20,12.5 µ/ml, mg/m
orabloc solution for injection in cartridge
pierrel pharma s.r.l., italy - articaine hydrochloride,adrenaline tartrate - solution for injection in cartridge - 40,18.2 mg/ml,
orabloc solution for injection in cartridge
pierrel pharma s.r.l., italy - articaine hydrochloride,adrenaline tartrate - solution for injection in cartridge - 40,9.1 mg/ml,
orabloc- articaine hydrochloride and epinephrine bitartrate injection
pierrel s.p.a. - articaine hydrochloride (unii: qs9014q792) (articaine - unii:d3sq406g9x), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - articaine hydrochloride 40 mg in 1 ml - orabloc is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age and older. orabloc is contraindicated in patients who are hypersensitive to products containing sulfites. products containing sulfites may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people [see warnings and precautions (5.5)] . teratogenic effects-pregnancy category c. there are no adequate and well-controlled studies in pregnant women with articaine with epinephrine. articaine hydrochloride and epinephrine (1:100,000) has been shown to increase fetal deaths and skeletal variations in rabbits when given in doses approximately 4 times the maximum recommended human dose (mrhd). orabloc should be used during pregnancy only if the potential benefit justifies the potentia
articaine hydrochloride and epinephrine bitartrate injection solution
pierrel s.p.a. - articaine hydrochloride; epinephrine bitartrate - solution - 40mg; 0.009mg - articaine hydrochloride 40mg; epinephrine bitartrate 0.009mg - local anesthetics
articaine hydrochloride and epinephrine bitartrate injection solution
pierrel s.p.a. - articaine hydrochloride; epinephrine bitartrate - solution - 40mg; 0.018mg - articaine hydrochloride 40mg; epinephrine bitartrate 0.018mg - local anesthetics
orabloc 1:200,000 solution
pierrel s.p.a. - articaine hydrochloride; epinephrine bitartrate - solution - 40mg; 0.009mg - articaine hydrochloride 40mg; epinephrine bitartrate 0.009mg - local anesthetics